New therapeutic strategy for atopic dermatitis by targeting CHI3L1/ITGA5 axis

Clin Transl Med. 2022 Feb;12(2):e739. doi: 10.1002/ctm2.739.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chitinase-3-Like Protein 1 / drug effects*
  • Dermatitis, Atopic / drug therapy*
  • Dermatitis, Atopic / pathology
  • Dermatitis, Atopic / physiopathology
  • Humans
  • Integrins / drug effects*

Substances

  • CHI3L1 protein, human
  • Chitinase-3-Like Protein 1
  • ITGA5 protein, human
  • Integrins